| Year |
Citation |
Score |
| 2019 |
Vanderwerff BR, Church KJ, Kawas LH, Harding JW. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Cytokine. 123: 154762. PMID 31254927 DOI: 10.1016/J.Cyto.2019.154762 |
0.767 |
|
| 2019 |
Wright JW, Church KJ, Harding JW. Hepatocyte Growth Factor and Macrophage-Stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer. Current Cancer Drug Targets. PMID 30914029 DOI: 10.2174/1568009619666190326130008 |
0.401 |
|
| 2019 |
Wright JW, Harding JW. Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30664507 DOI: 10.3233/Jad-181035 |
0.341 |
|
| 2018 |
Church KJ, Vanderwerff BR, Riggers RR, Mateo-Victoriano B, Fagnan M, Harris PH, LeValley JC, Harding JW. Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Anti-Cancer Drugs. PMID 29389804 DOI: 10.1097/Cad.0000000000000598 |
0.366 |
|
| 2016 |
Church KJ, Vanderwerff BR, Riggers RR, McMicheal MD, Mateo-Victoriano B, Sukumar SR, Harding JW. Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells. Anti-Cancer Drugs. PMID 27314431 DOI: 10.1097/Cad.0000000000000390 |
0.387 |
|
| 2015 |
Uribe PM, Kawas LH, Harding JW, Coffin AB. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Frontiers in Cellular Neuroscience. 9: 3. PMID 25674052 DOI: 10.3389/Fncel.2015.00003 |
0.77 |
|
| 2015 |
Wright JW, Harding JW. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 985-1000. PMID 25649658 DOI: 10.3233/Jad-142814 |
0.393 |
|
| 2015 |
Wright JW, Kawas LH, Harding JW. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology. 125: 26-46. PMID 25455861 DOI: 10.1016/J.Pneurobio.2014.11.004 |
0.767 |
|
| 2015 |
Vanderwerff B, Church K, Kawas L, Harding J. Abstract 3922: Novel hepatocyte growth factor and macrophage stimulating protein antagonists for the treatment of castration-resistant prostate cancer Cancer Research. 75: 3922-3922. DOI: 10.1158/1538-7445.Am2015-3922 |
0.74 |
|
| 2014 |
Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. The Journal of Pharmacology and Experimental Therapeutics. 351: 390-402. PMID 25187433 DOI: 10.1124/Jpet.114.218735 |
0.803 |
|
| 2014 |
Kawas LH, Church KJ, Lange M, Mcmicheal M, Yamamoto B, Harding JW. Abstract 729: Norleual a hepatocyte growth factor/c-Met inhibitor blocks malignant phenotypes in cancerous cells Cancer Research. 74: 729-729. DOI: 10.1158/1538-7445.Am2014-729 |
0.782 |
|
| 2014 |
Church KJ, Kawas L, Harding J, Lang M, McMicheal M. Abstract 2708: Development of allosteric regulators of the dimerization domains of the plasminogen-related growth factor family for the treatment of pancreatic cancer Cancer Research. 74: 2708-2708. DOI: 10.1158/1538-7445.Am2014-2708 |
0.791 |
|
| 2013 |
Natarajan R, Harding JW, Wright JW. A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats. Journal of Experimental Neuroscience. 7: 1-14. PMID 25157203 DOI: 10.4137/Jen.S11381 |
0.579 |
|
| 2013 |
Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Frontiers in Endocrinology. 4: 158. PMID 24298267 DOI: 10.3389/Fendo.2013.00158 |
0.771 |
|
| 2013 |
McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/Jpet.112.199497 |
0.778 |
|
| 2013 |
Kawas LH, Benoist CC, Harding JW, Wayman GA, Abu-Lail NI. Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 428-38. PMID 22960190 DOI: 10.1016/J.Nano.2012.08.008 |
0.767 |
|
| 2013 |
Wright JW, Harding JW. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. PflüGers Archiv : European Journal of Physiology. 465: 133-51. PMID 22535332 DOI: 10.1007/S00424-012-1102-2 |
0.319 |
|
| 2013 |
Kawas LH, Harris P, Church K, Wright JW, Harding JW. Abstract 926: The angiotensin IV analog Norleual acts as a hepatocyte growth factor/c-Met inhibitor in pancreatic cancer cells. Cancer Research. 73: 926-926. DOI: 10.1158/1538-7445.Am2013-926 |
0.783 |
|
| 2012 |
Wright JW, Wilson WL, Wakeling V, Boydstun AS, Jensen A, Kawas L, Harding JW. The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats. Brain Sciences. 2: 298-318. PMID 24961196 DOI: 10.3390/Brainsci2030298 |
0.793 |
|
| 2012 |
Wright JW, Harding JW. Importance of the brain Angiotensin system in Parkinson's disease. Parkinson's Disease. 2012: 860923. PMID 23213621 DOI: 10.1155/2012/860923 |
0.314 |
|
| 2012 |
Wright JW, Mizutani S, Harding JW. Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension. International Journal of Hypertension. 2012: 124758. PMID 22792446 DOI: 10.1155/2012/124758 |
0.358 |
|
| 2012 |
Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/Jpet.111.188136 |
0.776 |
|
| 2012 |
Kawas LH, Ward BC, Mojica C, Wright JW, Harding JW. Abstract B3: Angiotensin IV-Related Hepatocyte Growth Factor Antagonists act as Anti-Angiogenic Anti-Cancer Agents Clinical Cancer Research. 18: B3-B3. DOI: 10.1158/1078-0432.Mechres-B3 |
0.773 |
|
| 2011 |
Kawas LH, Yamamoto BJ, Wright JW, Harding JW. Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18. PMID 21859930 DOI: 10.1124/Jpet.111.185694 |
0.788 |
|
| 2011 |
Wright JW, Harding JW. Brain renin-angiotensin--a new look at an old system. Progress in Neurobiology. 95: 49-67. PMID 21777652 DOI: 10.1016/J.Pneurobio.2011.07.001 |
0.374 |
|
| 2011 |
Benoist CC, Wright JW, Zhu M, Appleyard SM, Wayman GA, Harding JW. Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs. The Journal of Pharmacology and Experimental Therapeutics. 339: 35-44. PMID 21719467 DOI: 10.1124/Jpet.111.182220 |
0.756 |
|
| 2011 |
Natarajan R, Wright JW, Harding JW. Nicotine-induced conditioned place preference in adolescent rats. Pharmacology, Biochemistry, and Behavior. 99: 519-23. PMID 21600911 DOI: 10.1016/J.Pbb.2011.05.004 |
0.513 |
|
| 2011 |
Kawas LH, Harding JW, Yamamoto BJ, Wright JW. Abstract 1356: The Hinge (linker) region of the Hepatocyte Growth Factor (HGF) peptide sequence can act as Hepatocyte Growth Factor/c-Met inhibitor Cancer Research. 71: 1356-1356. DOI: 10.1158/1538-7445.Am2011-1356 |
0.782 |
|
| 2010 |
Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW. The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73. PMID 20086056 DOI: 10.1124/Jpet.109.161711 |
0.76 |
|
| 2010 |
Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Experimental Neurology. 223: 326-33. PMID 19782074 DOI: 10.1016/J.Expneurol.2009.09.012 |
0.333 |
|
| 2009 |
Wright JW, Harding JW. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plasticity. 2009: 579382. PMID 20169175 DOI: 10.1155/2009/579382 |
0.34 |
|
| 2009 |
Wright JW, Meighan PC, Brown TE, Wiediger RV, Sorg BA, Harding JW. Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3. Behavioural Brain Research. 203: 27-34. PMID 19389428 DOI: 10.1016/J.Bbr.2009.04.014 |
0.737 |
|
| 2009 |
Wilson WL, Munn C, Ross RC, Harding JW, Wright JW. The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory. Brain Research. 1272: 25-31. PMID 19328191 DOI: 10.1016/J.Brainres.2009.03.025 |
0.33 |
|
| 2009 |
Wright JW, Harding JW. The brain angiotensin IV/AT4 receptor system as a new target for the treatment of Alzheimer's disease Drug Development Research. 70: 472-480. DOI: 10.1002/Ddr.20328 |
0.386 |
|
| 2008 |
Wright JW, Harding JW. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. Journal of the Renin-Angiotensin-Aldosterone System : Jraas. 9: 226-37. PMID 19126664 DOI: 10.1177/1470320308099084 |
0.332 |
|
| 2008 |
Brown TE, Forquer MR, Harding JW, Wright JW, Sorg BA. Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference. Synapse (New York, N.Y.). 62: 886-9. PMID 18792988 DOI: 10.1002/Syn.20562 |
0.315 |
|
| 2008 |
Wright JW, Yamamoto BJ, Harding JW. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Progress in Neurobiology. 84: 157-81. PMID 18160199 DOI: 10.1016/J.Pneurobio.2007.10.009 |
0.784 |
|
| 2008 |
Olson ML, Meighan PC, Brown TE, Asay AL, Benoist CC, Harding JW, Wright JW. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. Regulatory Peptides. 146: 19-25. PMID 17698214 DOI: 10.1016/J.Regpep.2007.07.004 |
0.783 |
|
| 2007 |
Meighan PC, Meighan SE, Davis CJ, Wright JW, Harding JW. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. Journal of Neurochemistry. 102: 2085-96. PMID 17587312 DOI: 10.1111/J.1471-4159.2007.04682.X |
0.779 |
|
| 2007 |
Wright JW, Brown TE, Harding JW. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plasticity. 2007: 73813. PMID 17502908 DOI: 10.1155/2007/73813 |
0.358 |
|
| 2006 |
Wright JW, Meighan SE, Murphy ES, Holtfreter KL, Davis CJ, Olson ML, Benoist CC, Muhunthan K, Harding JW. Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9. Behavioural Brain Research. 174: 78-85. PMID 16916548 DOI: 10.1016/J.Bbr.2006.07.006 |
0.738 |
|
| 2006 |
Davis CJ, Meighan PC, Taishi P, Krueger JM, Harding JW, Wright JW. REM sleep deprivation attenuates actin-binding protein cortactin: a link between sleep and hippocampal plasticity. Neuroscience Letters. 400: 191-6. PMID 16533564 DOI: 10.1016/J.Neulet.2006.02.046 |
0.735 |
|
| 2006 |
Meighan SE, Meighan PC, Choudhury P, Davis CJ, Olson ML, Zornes PA, Wright JW, Harding JW. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. Journal of Neurochemistry. 96: 1227-41. PMID 16464240 DOI: 10.1111/J.1471-4159.2005.03565.X |
0.786 |
|
| 2006 |
Davis CJ, Kramár EA, De A, Meighan PC, Simasko SM, Wright JW, Harding JW. AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation. Neuroscience. 137: 1369-79. PMID 16343778 DOI: 10.1016/J.Neuroscience.2005.10.051 |
0.752 |
|
| 2005 |
Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW, Wright JW. Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Research. 1060: 108-17. PMID 16182260 DOI: 10.1016/J.Brainres.2005.08.032 |
0.343 |
|
| 2005 |
Murphy ES, Harding JW, Muhunthan K, Holtfreter KL, Wright JW. Role of mitogen-activated protein kinases during recovery from head-shake response habituation in rats. Brain Research. 1050: 170-9. PMID 15963956 DOI: 10.1016/J.Brainres.2005.05.040 |
0.31 |
|
| 2004 |
Wright JW, Murphy ES, Elijah IE, Holtfreter KL, Davis CJ, Olson ML, Muhunthan K, Harding JW. Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats. Brain Research. 1023: 1-14. PMID 15364013 DOI: 10.1016/J.Brainres.2004.06.083 |
0.321 |
|
| 2004 |
Albiston AL, Pederson ES, Burns P, Purcell B, Wright JW, Harding JW, Mendelsohn FA, Weisinger RS, Chai SY. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms. Behavioural Brain Research. 154: 239-43. PMID 15302130 DOI: 10.1016/J.Bbr.2004.02.012 |
0.333 |
|
| 2004 |
Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Progress in Neurobiology. 72: 263-93. PMID 15142685 DOI: 10.1016/J.Pneurobio.2004.03.003 |
0.398 |
|
| 2004 |
Olson ML, Olson EA, Qualls JH, Stratton JJ, Harding JW, Wright JW. Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits. Peptides. 25: 233-41. PMID 15063004 DOI: 10.1016/J.Peptides.2003.12.005 |
0.344 |
|
| 2003 |
Wright JW, Kramár EA, Myers ED, Davis CJ, Harding JW. Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog. Regulatory Peptides. 113: 49-56. PMID 12686460 DOI: 10.1016/S0167-0115(02)00302-6 |
0.349 |
|
| 2003 |
Wright JW, Masino AJ, Reichert JR, Turner GD, Meighan SE, Meighan PC, Harding JW. Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases. Brain Research. 963: 252-61. PMID 12560131 DOI: 10.1016/S0006-8993(02)04036-2 |
0.777 |
|
| 2003 |
Wright JW, Tamura-Myers E, Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R725-33. PMID 12433674 DOI: 10.1152/Ajpregu.00326.2002 |
0.358 |
|
| 2002 |
Wright JW, Reichert JR, Davis CJ, Harding JW. Neural plasticity and the brain renin-angiotensin system. Neuroscience and Biobehavioral Reviews. 26: 529-52. PMID 12367589 DOI: 10.1016/S0149-7634(02)00019-2 |
0.373 |
|
| 2002 |
Wright JW, Kramár EA, Meighan SE, Harding JW. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. Peptides. 23: 221-46. PMID 11814638 DOI: 10.1016/S0196-9781(01)00599-X |
0.674 |
|
| 2001 |
Pederson ES, Krishnan R, Harding JW, Wright JW. A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits Regulatory Peptides. 102: 147-156. PMID 11730987 DOI: 10.1016/S0167-0115(01)00312-3 |
0.381 |
|
| 2001 |
Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW. Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides. 22: 1403-14. PMID 11514021 DOI: 10.1016/S0196-9781(01)00475-2 |
0.378 |
|
| 2001 |
Hamilton TA, Handa RK, Harding JW, Wright JW. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat Peptides. 22: 935-944. PMID 11390024 DOI: 10.1016/S0196-9781(01)00405-3 |
0.31 |
|
| 2001 |
Kramár EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Research. 897: 114-21. PMID 11282364 DOI: 10.1016/S0006-8993(01)02100-X |
0.415 |
|
| 1999 |
Slinker BK, Wu Y, Brennan AJ, Campbell KB, Harding JW. Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation Cardiovascular Research. 42: 660-669. PMID 10533606 DOI: 10.1016/S0008-6363(98)00344-7 |
0.332 |
|
| 1999 |
Wright JW, Stubley L, Pederson ES, Kramár EA, Hanesworth JM, Harding JW. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 3952-61. PMID 10234025 DOI: 10.1523/Jneurosci.19-10-03952.1999 |
0.352 |
|
| 1998 |
Pederson ES, Harding JW, Wright JW. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog Regulatory Peptides. 74: 97-103. PMID 9712169 DOI: 10.1016/S0167-0115(98)00028-7 |
0.326 |
|
| 1998 |
Coleman JK, Krebs LT, Hamilton TA, Ong B, Lawrence KA, Sardinia MF, Harding JW, Wright JW. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides. 19: 269-77. PMID 9493859 DOI: 10.1016/S0196-9781(97)00291-X |
0.321 |
|
| 1998 |
Handa RK, Krebs LT, Harding JW, Handa SE. Angiotensin IV AT4-receptor system in the rat kidney American Journal of Physiology - Renal Physiology. 274: F290-F299. PMID 9486224 DOI: 10.1152/Ajprenal.1998.274.2.F290 |
0.365 |
|
| 1997 |
Wright JW, Harding JW. Important roles for angiotensin III and IV in the brain renin- angiotensin system Brain Research Reviews. 25: 96-124. PMID 9370053 DOI: 10.1016/S0165-0173(97)00019-2 |
0.375 |
|
| 1997 |
Yang Q, Hanesworth JM, Harding JW, Slinker BK. The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart. Regulatory Peptides. 71: 175-83. PMID 9350976 DOI: 10.1016/S0167-0115(97)01033-1 |
0.358 |
|
| 1997 |
Kramár EA, Harding JW, Wright JW. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes. Regulatory Peptides. 68: 131-8. PMID 9110385 DOI: 10.1016/S0167-0115(96)02116-7 |
0.364 |
|
| 1996 |
Wright JW, Bechtholt AJ, Chambers SL, Harding JW. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides. 17: 1365-71. PMID 8971933 DOI: 10.1016/S0196-9781(96)00226-4 |
0.355 |
|
| 1996 |
Batt CM, Jensen LL, Harding JW, Wright JW. Microinfusion of aminopeptidase M into the paraventricular nucleus of the hypothalamus in normotensive and hypertensive rats Brain Research Bulletin. 39: 235-240. PMID 8963689 DOI: 10.1016/0361-9230(95)02141-8 |
0.329 |
|
| 1996 |
Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW. Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regulatory Peptides. 67: 123-30. PMID 8958583 DOI: 10.1016/S0167-0115(96)00121-8 |
0.376 |
|
| 1996 |
Moeller I, Small DH, Reed G, Harding JW, Mendelsohn FA, Chai SY. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Research. 725: 61-6. PMID 8828586 DOI: 10.1016/0006-8993(96)00246-6 |
0.359 |
|
| 1996 |
Wright JW, Clemens JA, Panetta JA, Smalstig EB, Weatherly LA, Kramár EA, Pederson ES, Mungall BH, Harding JW. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Research. 717: 1-11. PMID 8738247 DOI: 10.1016/0006-8993(95)01454-3 |
0.329 |
|
| 1995 |
Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regulatory Peptides. 58: 107-15. PMID 8577922 DOI: 10.1016/0167-0115(95)00068-M |
0.346 |
|
| 1995 |
Wright JW, Hamilton TA, Harding JW. Anomalous effects of losartan on aminopeptidase-induced reductions of blood pressure in SHR Brain Research Bulletin. 36: 169-174. PMID 7895095 DOI: 10.1016/0361-9230(94)00186-5 |
0.376 |
|
| 1995 |
Wright JW, Krebs LT, Stobb JW, Harding JW. The Angiotensin IV System: Functional Implications Frontiers in Neuroendocrinology. 16: 23-52. PMID 7768321 DOI: 10.1006/Frne.1995.1002 |
0.347 |
|
| 1995 |
Roberts KA, Krebs LT, Kramár EA, Shaffer MJ, Harding JW, Wright JW. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Research. 682: 13-21. PMID 7552303 DOI: 10.1016/0006-8993(95)00289-3 |
0.377 |
|
| 1994 |
Wright JW, Harding JW. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses Neuroscience and Biobehavioral Reviews. 18: 21-53. PMID 8170622 DOI: 10.1016/0149-7634(94)90034-5 |
0.372 |
|
| 1994 |
Sardinia MF, Hanesworth JM, Krishnan F, Harding JW. AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues Peptides. 15: 1399-1406. PMID 7700843 DOI: 10.1016/0196-9781(94)90115-5 |
0.328 |
|
| 1994 |
Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT. AT4 receptors: Specificity and distribution Kidney International. 46: 1510-1512. PMID 7699992 DOI: 10.1038/Ki.1994.432 |
0.334 |
|
| 1993 |
Cook VI, Grove KL, Speth RC, McMenamin KM, Harding JW. Differences between perinatal angiotensin binding in the brains of SHR and WKY rats Regulatory Peptides. 45: 395-405. PMID 8351405 DOI: 10.1016/0167-0115(93)90366-G |
0.355 |
|
| 1993 |
Sardinia MF, Hanesworth JM, Krebs LT, Harding JW. AT4 receptor binding characteristics: d-Amino acid- and glycine-substituted peptides Peptides. 14: 949-954. PMID 8284271 DOI: 10.1016/0196-9781(93)90071-N |
0.329 |
|
| 1993 |
Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW. Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Research Bulletin. 32: 497-502. PMID 8221142 DOI: 10.1016/0361-9230(93)90297-O |
0.335 |
|
| 1993 |
Wright JW, Roberts KA, Stubley LA, Hanesworth JM, Harding JW. Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats. Brain Research Bulletin. 31: 649-54. PMID 8100178 DOI: 10.1016/0361-9230(93)90136-Y |
0.304 |
|
| 1993 |
Roberts KA, Wright JW, Harding JW. GABA and bicuculline-induced blood pressure changes in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 21: 156-62. PMID 7678672 DOI: 10.1097/00005344-199301000-00023 |
0.301 |
|
| 1992 |
Harding JW, Jensen LL, Hanesworth JM, Roberts KA, Page TA, Wright JW. Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. The American Journal of Physiology. 262: F17-23. PMID 1733292 DOI: 10.1152/Ajprenal.1992.262.1.F17 |
0.321 |
|
| 1992 |
Jensen LL, Harding JW, Wright JW. Role of paraventricular nucleus in control of blood pressure and drinking in rats American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 262: F1068-F1075. PMID 1621811 DOI: 10.1152/Ajprenal.1992.262.6.F1068 |
0.343 |
|
| 1992 |
Swanson GN, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor Regulatory Peptides. 40: 409-419. PMID 1438983 DOI: 10.1016/0167-0115(92)90527-2 |
0.36 |
|
| 1992 |
Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses Brain Research Reviews. 17: 227-262. PMID 1361394 DOI: 10.1016/0165-0173(92)90018-H |
0.339 |
|
| 1991 |
Siemens IR, Swanson GN, Fluharty SJ, Harding JW. Solubilization and partial characterization of angiotensin II receptors from rat brain. Journal of Neurochemistry. 57: 690-700. PMID 2072111 DOI: 10.1111/J.1471-4159.1991.Tb03801.X |
0.344 |
|
| 1991 |
Murray CE, Harding JW, Wright JW. Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains Pharmacology, Biochemistry and Behavior. 39: 1029-1032. PMID 1763099 DOI: 10.1016/0091-3057(91)90071-9 |
0.348 |
|
| 1991 |
Cook VI, Grove KL, McMenamin KM, Carter MR, Harding JW, Speth RC. The AT2 angiotensin receptor subtype predominates in the 18 day gestation fetal rat brain Brain Research. 560: 334-336. PMID 1760741 DOI: 10.1016/0006-8993(91)91254-X |
0.33 |
|
| 1991 |
Wright JW, Amir HZ, Murray CE, Roberts KA, Harding JW, Mizutani S, Ward PE. Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats. Brain Research Bulletin. 27: 545-51. PMID 1684525 DOI: 10.1016/0361-9230(91)90027-H |
0.366 |
|
| 1991 |
Hall KL, Harding JW, Hosick HL. Isolation and characterization of clonal vascular smooth muscle cell lines from spontaneously hypertensive and normotensive rat aortas In Vitro Cellular and Developmental Biology - Animal. 27: 791-798. PMID 1660051 DOI: 10.1007/Bf02631245 |
0.305 |
|
| 1990 |
Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Research. 514: 5-10. PMID 2357530 DOI: 10.1016/0006-8993(90)90428-E |
0.35 |
|
| 1990 |
Cook VI, Wright JW, Wright SA, Harding JW. Comparison of angiotensin metabolism by brain membranes from SHR and WKY rats Brain Research. 529: 320-323. PMID 2282500 DOI: 10.1016/0006-8993(90)90844-2 |
0.314 |
|
| 1990 |
Batt CM, Jensen LL, Hanesworth JM, Harding JW, Wright JW. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels Brain Research. 529: 126-130. PMID 2282487 DOI: 10.1016/0006-8993(90)90819-W |
0.324 |
|
| 1990 |
Wright JW, Mizutani S, Murray CE, Amir HZ, Harding JW. Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat Journal of Hypertension. 8: 969-974. PMID 2174951 DOI: 10.1097/00004872-199010000-00013 |
0.331 |
|
| 1989 |
Jensen LL, Harding JW, Wright JW. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains Brain Research. 490: 48-55. PMID 2758329 DOI: 10.1016/0006-8993(89)90429-0 |
0.312 |
|
| 1989 |
Harding JW, Jensen LL, Quirk WS, Dewey AL, Wright JW. Brain angiotensin: Critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function Peptides. 10: 261-264. PMID 2755868 DOI: 10.1016/0196-9781(89)90028-4 |
0.337 |
|
| 1989 |
Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW. Structure-function analyses of brain angiotensin control of pressor action in rats. The American Journal of Physiology. 257: R1551-7. PMID 2604011 DOI: 10.1152/Ajpregu.1989.257.6.R1551 |
0.342 |
|
| 1988 |
Quirk WS, Wright JW, Harding JW. Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins Brain Research. 452: 73-78. PMID 3401750 DOI: 10.1016/0006-8993(88)90010-8 |
0.371 |
|
| 1988 |
King SJ, Harding JW, Moe KE. Elevated salt appetite and brain binding of angiotensin II in mineralocorticoid-treated rats Brain Research. 448: 140-149. PMID 3390713 DOI: 10.1016/0006-8993(88)91110-9 |
0.355 |
|
| 1988 |
Dewey AL, Wright JW, Hanesworth JM, Harding JW. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat Brain Research. 448: 369-372. PMID 3378160 DOI: 10.1016/0006-8993(88)91279-6 |
0.355 |
|
| 1988 |
Jensen LL, Harding JW, Wright JW. Central effects of a specific angiotensin receptor antagonist, sarthran (Sar1, Thr8All) in normotensive and spontaneously hypertensive rat strains Brain Research. 448: 359-363. PMID 3378158 DOI: 10.1016/0006-8993(88)91277-2 |
0.324 |
|
| 1988 |
Wright JW, Quirk WS, Hanesworth JM, Harding JW. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats Brain Research. 441: 215-220. PMID 3359232 DOI: 10.1016/0006-8993(88)91401-1 |
0.362 |
|
| 1988 |
Abhold RH, Hanesworth JM, Harding JW. Comparison of 125I-angiotensin III and 125I-angiotensin II binding to rat brain membranes Journal of Neurochemistry. 50: 831-838. PMID 3339357 DOI: 10.1111/J.1471-4159.1988.Tb02988.X |
0.322 |
|
| 1988 |
Harding JW, Sullivan MJ, Hanesworth JM, Cushing LL, Wright JW. Inability of [125I]Sar1,Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments Journal of Neurochemistry. 50: 554-557. PMID 3335860 DOI: 10.1111/J.1471-4159.1988.Tb02946.X |
0.315 |
|
| 1988 |
Wright JW, Roberts KA, Harding JW. Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR. Peptides. 9: 979-84. PMID 3244565 DOI: 10.1016/0196-9781(88)90076-9 |
0.307 |
|
| 1988 |
Batt CM, Klein EW, Harding JW, Wright JW. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran Brain Research Bulletin. 21: 731-735. PMID 3219604 DOI: 10.1016/0361-9230(88)90039-1 |
0.391 |
|
| 1988 |
Sullivan MJ, Harding JW, Wright JW. Differential effects of aminopeptides inhibitors on angiotensin-induced pressor responses Brain Research. 456: 249-253. PMID 3208081 DOI: 10.1016/0006-8993(88)90224-7 |
0.381 |
|
| 1987 |
Harding JW, Felix D. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain Brain Research. 424: 299-304. PMID 3676828 DOI: 10.1016/0006-8993(87)91474-0 |
0.404 |
|
| 1987 |
Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW. Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat Brain Research. 420: 289-294. PMID 3676761 DOI: 10.1016/0006-8993(87)91249-2 |
0.356 |
|
| 1987 |
Rogulja I, Harding JW, Ritter S. Reduction of 125I-angiotensin II binding sites in rat brain following monosodium glutamate treatment Brain Research. 419: 333-335. PMID 3676737 DOI: 10.1016/0006-8993(87)90603-2 |
0.322 |
|
| 1987 |
Quirk WS, Harding JW, Wright JW. Amastatin and bestatin-Induced dipsogenicity in the fSprague-Dawley Rat Brain Research Bulletin. 19: 145-147. PMID 3651838 DOI: 10.1016/0361-9230(87)90178-X |
0.373 |
|
| 1987 |
Wright JW, Morseth SL, Fairley PC, Petersen EP, Harding JW. Angiotensin's contribution to dipsogenic additivity in several rodent species Behavioral Neuroscience. 101: 361-370. PMID 3606809 DOI: 10.1037//0735-7044.101.3.361 |
0.337 |
|
| 1987 |
Wright JW, Sullivan MJ, Bredl CR, Hanesworth JM, Cushing LL, Harding JW. Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat Journal of Neurochemistry. 49: 651-654. PMID 3598591 DOI: 10.1111/J.1471-4159.1987.Tb02913.X |
0.354 |
|
| 1987 |
Harding JW, Felix D. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III Brain Research. 410: 130-134. PMID 3580891 DOI: 10.1016/S0006-8993(87)80033-1 |
0.343 |
|
| 1987 |
Imboden H, Harding JW, Hilgenfeldt U, Celio MR, Felix D. Localization of angiotensinogen in multiple cell types of rat brain Brain Research. 410: 74-77. PMID 3555708 DOI: 10.1016/S0006-8993(87)80022-7 |
0.304 |
|
| 1987 |
Imboden H, Harding JW, Ganten D, Felix D. Comparison of angiotensin II staining in rat brain using affinity purified and crude antisera Clinical and Experimental Hypertension. 1133-1139. PMID 2441911 DOI: 10.3109/10641968709160038 |
0.318 |
|
| 1986 |
Harding JW, Yoshida MS, Dilts RP, Woods TM, Wright JW. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat Journal of Neurochemistry. 46: 1292-1297. PMID 3950629 DOI: 10.1111/J.1471-4159.1986.Tb00652.X |
0.307 |
|
| 1986 |
Wright JW, Sullivan MJ, Petersen EP, Harding JW. Brain angiotensin II and III binding and dipsogenicity in the rabbit. Brain Research. 358: 376-9. PMID 3935273 DOI: 10.1016/0006-8993(85)90988-6 |
0.328 |
|
| 1986 |
Hwang BH, Wu JY, Wieczorek CM, Harding JW, Erickson JB, Wamsley JK. Different pharmacological anatomy in the paraventricular hypothalamic nucleus, supraoptic nucleus, and suprachiasmatic nucleus of rats: Quantitative autoradiography on angiotensin II receptor binding sites American Journal of Anatomy. 176: 243-247. PMID 3017087 DOI: 10.1002/Aja.1001760212 |
0.337 |
|
| 1986 |
Harding JW, Erickson JB, Camara CC, Abhold RH, Wright JW. High-performance liquid chromatographic analysis of 'specifically bound' label after [125I]angiotensin II binding to rat brain membranes Neuroscience Letters. 65: 23-28. PMID 3010190 DOI: 10.1016/0304-3940(86)90114-X |
0.323 |
|
| 1986 |
Hwang BH, Harding JW, Liu DK, Hibbard LS, Wieczorek CM, Wu JY. Quantitative autoradiography of 125I-[Sar1, Ile8]-angiotensin II binding in the brain of spontaneously hypertensive rats. Brain Research Bulletin. 16: 75-82. PMID 3006878 DOI: 10.1016/0361-9230(86)90014-6 |
0.322 |
|
| 1986 |
Wright JW, Sullivan MJ, Harding JW. Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats. Neuroscience Letters. 61: 351-6. PMID 3001599 DOI: 10.1016/0304-3940(85)90489-6 |
0.341 |
|
| 1985 |
Wright JW, Morseth SL, Abhold RH, Harding JW. Pressor action and dipsogenicity induced by angiotensin II and III in rats. The American Journal of Physiology. 249: R514-21. PMID 4061676 DOI: 10.1152/Ajpregu.1985.249.5.R514 |
0.348 |
|
| 1985 |
Petersen EP, Abhold RH, Camara CG, Wright JW, Harding JW. Characterization of angiotensin binding in the African green monkey. Brain Research. 341: 139-46. PMID 4041782 DOI: 10.1016/0006-8993(85)91481-7 |
0.312 |
|
| 1985 |
Petersen EP, Wright JW, Harding JW. Characterization of angiotensin II binding sites in African Green monkey uterus. Life Sciences. 36: 177-182. PMID 2981383 DOI: 10.1016/0024-3205(85)90097-9 |
0.333 |
|
| 1984 |
Wright JW, Morseth S, Mana MJ, LaCrosse E, Petersen EP, Harding JW. Central angiotensin III-induced dipsogenicity in rats and gerbils. Brain Research. 295: 121-6. PMID 6713170 DOI: 10.1016/0006-8993(84)90822-9 |
0.365 |
|
| 1984 |
Petersen EP, Camara CG, Abhold RH, Wright JW, Harding JW. Characterization of angiotensin binding to gerbil brain membranes using [125I]angiotensin III as the radioligand. Brain Research. 321: 225-35. PMID 6498516 DOI: 10.1016/0006-8993(84)90176-8 |
0.308 |
|
| 1984 |
Wright JW, Morseth SL, LaCrosse E, Harding JW. Angiotensin III-induced dipsogenic and pressor responses in rodents. Behavioral Neuroscience. 98: 640-651. PMID 6380522 DOI: 10.1037//0735-7044.98.4.640 |
0.335 |
|
| 1978 |
Harding JW, Getchell TV, Margolis FL. Denervation of the primary olfactory pathway in mice. V. Long-term effect of intranasal ZnSO4 irrigation on behavior, biochemistry and morphology. Brain Research. 140: 271-85. PMID 626892 DOI: 10.1016/0006-8993(78)90460-2 |
0.49 |
|
| 1977 |
Monti-Graziadei GA, Margolis FL, Harding JW, Graziadei PP. Immunocytochemistry of the olfactory marker protein. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 25: 1311-6. PMID 336785 DOI: 10.1177/25.12.336785 |
0.464 |
|
| 1976 |
Harding J, Margolis FL. Denervation in the primary olfactory pathway of mice. III. Effect on enzymes of carnosine metabolism Brain Research. 110: 351-360. PMID 938948 DOI: 10.1016/0006-8993(76)90407-8 |
0.513 |
|
| Show low-probability matches. |